Page last updated: 2024-11-08

biguanides and Cancer of Prostate

biguanides has been researched along with Cancer of Prostate in 2 studies

Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jiménez-Vacas, JM1
Herrero-Aguayo, V1
Montero-Hidalgo, AJ1
Sáez-Martínez, P1
Gómez-Gómez, E1
León-González, AJ1
Fuentes-Fayos, AC1
Yubero-Serrano, EM1
Requena-Tapia, MJ1
López, M1
Castaño, JP1
Gahete, MD1
Luque, RM1
Gormsen, J1

Other Studies

2 other studies available for biguanides and Cancer of Prostate

ArticleYear
Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
    The Journal of clinical endocrinology and metabolism, 2021, 01-23, Volume: 106, Issue:2

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Biguanides; Cell Line, Tumor;

2021
Fibrinolytic activity and haemagglutination inhibition immunoassays.
    Scandinavian journal of haematology, 1970, Volume: 7, Issue:4

    Topics: Adult; Aged; Biguanides; Clofibrate; Coronary Disease; Ethylestrenol; Female; Fibrin; Fibrinogen; Fi

1970